Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern

Overview of attention for article published in Frontiers in immunology, January 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Dimensions has found 3 publications that cite this research output.

Article in Frontiers in Immunology (March 2024)

Preprint in bioRxiv (February 2024)

Article in Journal of Applied Biomaterials & Functional Materials (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.